Cargando…
LKB1 deletion with the RIP2.Cre transgene modifies pancreatic β-cell morphology and enhances insulin secretion in vivo
The tumor suppressor liver kinase B1 (LKB1), also called STK11, is a protein kinase mutated in Peutz-Jeghers syndrome. LKB1 phosphorylates AMP-activated protein kinase (AMPK) and several related protein kinases. Whereas deletion of both catalytic isoforms of AMPK from the pancreatic β-cell and hypot...
Autores principales: | Sun, Gao, Tarasov, Andrei I., McGinty, James A., French, Paul M., McDonald, Angela, Leclerc, Isabelle, Rutter, Guy A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Physiological Society
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886523/ https://www.ncbi.nlm.nih.gov/pubmed/20354156 http://dx.doi.org/10.1152/ajpendo.00100.2010 |
Ejemplares similares
-
RIP2-mediated LKB1 deletion causes axon degeneration in the spinal cord and hind-limb paralysis
por: Sun, Gao, et al.
Publicado: (2011) -
Transcription factor-7–like 2 (TCF7L2) gene acts downstream of the Lkb1/Stk11 kinase to control mTOR signaling, β cell growth, and insulin secretion
por: Nguyen-Tu, Marie-Sophie, et al.
Publicado: (2018) -
LKB1 and AMPK differentially regulate pancreatic β-cell identity
por: Kone, Marina, et al.
Publicado: (2014) -
Tamoxifen-Independent Recombination in the RIP-CreER Mouse
por: Liu, Yanmei, et al.
Publicado: (2010) -
Animal Models of GWAS-Identified Type 2 Diabetes Genes
por: da Silva Xavier, Gabriela, et al.
Publicado: (2013)